Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Topological gene expression networks recapitulate brain anatomy and function.

Patania A, Selvaggi P, Veronese M, Dipasquale O, Expert P, Petri G.

Netw Neurosci. 2019 Jul 1;3(3):744-762. doi: 10.1162/netn_a_00094. eCollection 2019.

2.

The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.

D'Ambrosio E, Dahoun T, Pardiñas AF, Veronese M, Bloomfield MAP, Jauhar S, Bonoldi I, Rogdaki M, Froudist-Walsh S, Walters JTR, Howes OD.

Psychiatry Res Neuroimaging. 2019 Jul 19;291:34-41. doi: 10.1016/j.pscychresns.2019.07.005. [Epub ahead of print]

PMID:
31386983
3.

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.

Borgan F, Laurikainen H, Veronese M, Marques TR, Haaparanta-Solin M, Solin O, Dahoun T, Rogdaki M, Salokangas RK, Karukivi M, Di Forti M, Turkheimer F, Hietala J, Howes O; METSY Group.

JAMA Psychiatry. 2019 Jul 3. doi: 10.1001/jamapsychiatry.2019.1427. [Epub ahead of print]

4.

Tapering of SSRI treatment to mitigate withdrawal symptoms.

Selvaraj S, Jauhar S, Baldwin DS, Cowen PJ, Goodwin G, Hayes JF, Nutt DJ, Veronese M, Young AH.

Lancet Psychiatry. 2019 Jul;6(7):560-561. doi: 10.1016/S2215-0366(19)30183-X. No abstract available.

PMID:
31230676
5.

Correction: Regulation of dopaminergic function: An [18F]-DOPA PET apomorphine challenge study in humans.

Jauhar S, Veronese M, Rogdaki M, Bloomfield M, Natesan S, Turkheimer F, Kapur S, Howes OD.

Transl Psychiatry. 2019 Jun 11;9(1):168. doi: 10.1038/s41398-019-0501-y.

6.

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.

Borgan F, Beck K, Butler E, McCutcheon R, Veronese M, Vernon A, Howes OD.

Psychopharmacology (Berl). 2019 Jun 5. doi: 10.1007/s00213-019-05283-3. [Epub ahead of print]

PMID:
31165913
7.

Head-to-head comparison of 11C-PBR28 and 11C-ER176 for quantification of the translocator protein in the human brain.

Zanotti-Fregonara P, Pascual B, Veronese M, Yu M, Beers D, Appel SH, Masdeu JC.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1822-1829. doi: 10.1007/s00259-019-04349-w. Epub 2019 May 31.

PMID:
31152207
8.

The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study.

Dahoun T, Calcia MA, Veronese M, Bloomfield P, Reis Marques T, Turkheimer F, Howes OD.

Brain Behav Immun. 2019 Aug;80:742-750. doi: 10.1016/j.bbi.2019.05.023. Epub 2019 May 18.

PMID:
31112791
9.

Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA.

Dipasquale O, Selvaggi P, Veronese M, Gabay AS, Turkheimer F, Mehta MA.

Neuroimage. 2019 Jul 15;195:252-260. doi: 10.1016/j.neuroimage.2019.04.007. Epub 2019 Apr 4.

10.

Dynamic 11C-PiB PET shows cerebrospinal fluid flow alterations in Alzheimer's disease and multiple sclerosis.

Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, Brooks DJ, Bertoldo A, Edison P, Turkheimer F.

J Nucl Med. 2019 Mar 8. pii: jnumed.118.223834. doi: 10.2967/jnumed.118.223834. [Epub ahead of print]

PMID:
30850505
11.

Covariance statistics and network analysis of brain PET imaging studies.

Veronese M, Moro L, Arcolin M, Dipasquale O, Rizzo G, Expert P, Khan W, Fisher PM, Svarer C, Bertoldo A, Howes O, Turkheimer FE.

Sci Rep. 2019 Feb 21;9(1):2496. doi: 10.1038/s41598-019-39005-8.

12.

Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT.

Safee ZM, Baark F, Waters ECT, Veronese M, Pell VR, Clark JE, Mota F, Livieratos L, Eykyn TR, Blower PJ, Southworth R.

Sci Rep. 2019 Jan 18;9(1):216. doi: 10.1038/s41598-018-36721-5.

13.

The validity of 18F-GE180 as a TSPO imaging agent.

Zanotti-Fregonara P, Veronese M, Pascual B, Rostomily RC, Turkheimer F, Masdeu JC.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1205-1207. doi: 10.1007/s00259-019-4268-4. Epub 2019 Jan 17. No abstract available.

PMID:
30656358
14.

Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis.

Borgan F, O'Daly O, Hoang K, Veronese M, Withers D, Batterham R, Howes O.

JAMA Netw Open. 2019 Jan 4;2(1):e186893. doi: 10.1001/jamanetworkopen.2018.6893.

15.

A mini-invasive procedure for the treatment of supralevator abscess of cryptoglandular origin by extrasphincteric extension: preliminary results at 1-year follow-up.

Schiano di Visconte M, Piccoli G, Brusciano L, Docimo L, Veronese M.

Int J Colorectal Dis. 2019 Apr;34(4):763-767. doi: 10.1007/s00384-019-03243-z. Epub 2019 Jan 15.

PMID:
30645671
16.

Increased cerebral blood flow after single dose of antipsychotics in healthy volunteers depends on dopamine D2 receptor density profiles.

Selvaggi P, Hawkins PCT, Dipasquale O, Rizzo G, Bertolino A, Dukart J, Sambataro F, Pergola G, Williams SCR, Turkheimer F, Zelaya F, Veronese M, Mehta MA.

Neuroimage. 2019 Mar;188:774-784. doi: 10.1016/j.neuroimage.2018.12.028. Epub 2018 Dec 13.

PMID:
30553916
17.

Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [18F]DOPA PET and fMRI study.

Kim S, Jung WH, Howes OD, Veronese M, Turkheimer FE, Lee YS, Lee JS, Kim E, Kwon JS.

Psychol Med. 2018 Nov 21:1-10. doi: 10.1017/S0033291718003471. [Epub ahead of print]

PMID:
30460891
18.

Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study.

McCutcheon RA, Nour MM, Dahoun T, Jauhar S, Pepper F, Expert P, Veronese M, Adams RA, Turkheimer F, Mehta MA, Howes OD.

Biol Psychiatry. 2019 Mar 1;85(5):368-378. doi: 10.1016/j.biopsych.2018.09.010. Epub 2018 Sep 29.

19.

Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies.

Marques TR, Ashok AH, Pillinger T, Veronese M, Turkheimer FE, Dazzan P, Sommer IEC, Howes OD.

Psychol Med. 2018 Oct 25:1-11. doi: 10.1017/S0033291718003057. [Epub ahead of print]

20.

A Unified Framework for Plasma Data Modeling in Dynamic Positron Emission Tomography Studies.

Tonietto M, Rizzo G, Veronese M, Borgan F, Bloomfield PS, Howes O, Bertoldo A.

IEEE Trans Biomed Eng. 2019 May;66(5):1447-1455. doi: 10.1109/TBME.2018.2874308. Epub 2018 Oct 9.

PMID:
30307849
21.

Sex difference in brain CB1 receptor availability in man.

Laurikainen H, Tuominen L, Tikka M, Merisaari H, Armio RL, Sormunen E, Borgan F, Veronese M, Howes O, Haaparanta-Solin M, Solin O, Hietala J; METSY group.

Neuroimage. 2019 Jan 1;184:834-842. doi: 10.1016/j.neuroimage.2018.10.013. Epub 2018 Oct 5.

PMID:
30296558
22.

Ribosomal RACK1 promotes proliferation of neuroblastoma cells independently of global translation upregulation.

Romano N, Veronese M, Manfrini N, Zolla L, Ceci M.

Cell Signal. 2019 Jan;53:102-110. doi: 10.1016/j.cellsig.2018.09.020. Epub 2018 Oct 1.

PMID:
30287278
23.

GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models.

Horder J, Andersson M, Mendez MA, Singh N, Tangen Ä, Lundberg J, Gee A, Halldin C, Veronese M, Bölte S, Farde L, Sementa T, Cash D, Higgins K, Spain D, Turkheimer F, Mick I, Selvaraj S, Nutt DJ, Lingford-Hughes A, Howes OD, Murphy DG, Borg J.

Sci Transl Med. 2018 Oct 3;10(461). pii: eaam8434. doi: 10.1126/scitranslmed.aam8434.

24.

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.

Jauhar S, McCutcheon R, Borgan F, Veronese M, Nour M, Pepper F, Rogdaki M, Stone J, Egerton A, Turkheimer F, McGuire P, Howes OD.

Lancet Psychiatry. 2018 Oct;5(10):816-823. doi: 10.1016/S2215-0366(18)30268-2. Epub 2018 Sep 17. Erratum in: Lancet Psychiatry. 2018 Dec;5(12):e28.

25.

Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging.

Singh N, Veronese M, O'Doherty J, Sementa T, Bongarzone S, Cash D, Simmons C, Arcolin M, Marsden PK, Gee A, Turkheimer FE.

Nucl Med Biol. 2018 Nov;66:32-39. doi: 10.1016/j.nucmedbio.2018.08.005. Epub 2018 Aug 30.

26.

Correction: Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.

Jauhar S, Veronese M, Rogdaki M, Bloomfield M, Natesan S, Turkheimer F, Kapur S, Howes OD.

Transl Psychiatry. 2018 Aug 31;8(1):171. doi: 10.1038/s41398-018-0187-6.

27.

The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.

Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Natesan S, Turkheimer F, Stone J, Egerton A, McGuire P, Kapur S, Howes OD.

Biol Psychiatry. 2019 Jan 1;85(1):79-87. doi: 10.1016/j.biopsych.2018.07.003. Epub 2018 Jul 11.

28.

Coherent THz Emission Enhanced by Coherent Synchrotron Radiation Wakefield.

Di Mitri S, Perucchi A, Adhlakha N, Di Pietro P, Nicastro S, Roussel E, Spampinati S, Veronese M, Allaria E, Badano L, Cudin I, De Ninno G, Diviacco B, Gaio G, Gauthier D, Giannessi L, Lupi S, Penco G, Piccirilli F, Rebernik P, Spezzani C, Trovò M.

Sci Rep. 2018 Aug 3;8(1):11661. doi: 10.1038/s41598-018-30125-1.

29.

The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.

Dahoun T, Pardiñas AF, Veronese M, Bloomfield MAP, Jauhar S, Bonoldi I, Froudist-Walsh S, Nosarti C, Korth C, Hennah W, Walters J, Prata D, Howes OD.

Hum Mol Genet. 2018 Oct 15;27(20):3498-3506. doi: 10.1093/hmg/ddy242.

30.

Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study.

Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Turkheimer FE, Stone J, Egerton A, McGuire P, Kapur S, Howes OD.

Mol Psychiatry. 2018 Apr 20. doi: 10.1038/s41380-018-0042-4. [Epub ahead of print]

PMID:
29679071
31.

Substitution of venous for arterial blood sampling in the determination of regional rates of cerebral protein synthesis with L-[1-11C]leucine PET: A validation study.

Tomasi G, Veronese M, Bertoldo A, Smith CB, Schmidt KC.

J Cereb Blood Flow Metab. 2018 Apr 17:271678X18771242. doi: 10.1177/0271678X18771242. [Epub ahead of print]

PMID:
29664322
32.

Effects of shortened scanning intervals on calculated regional rates of cerebral protein synthesis determined with the L-[1-11C]leucine PET method.

Tomasi G, Veronese M, Bertoldo A, Beebe Smith C, Schmidt KC.

PLoS One. 2018 Apr 16;13(4):e0195580. doi: 10.1371/journal.pone.0195580. eCollection 2018.

33.

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S.

Biol Psychiatry. 2018 Sep 15;84(6):433-442. doi: 10.1016/j.biopsych.2018.02.1171. Epub 2018 Mar 6.

34.

Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

Fan Z, Dani M, Femminella GD, Wood M, Calsolaro V, Veronese M, Turkheimer F, Gentleman S, Brooks DJ, Hinz R, Edison P.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1432-1441. doi: 10.1007/s00259-018-3984-5. Epub 2018 Mar 9.

35.

Impact of tissue kinetic heterogeneity on PET quantification: case study with the L-[1-11C]leucine PET method for cerebral protein synthesis rates.

Veronese M, Bertoldo A, Tomasi G, Smith CB, Schmidt KC.

Sci Rep. 2018 Jan 17;8(1):931. doi: 10.1038/s41598-017-18890-x.

36.

The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life.

Froudist-Walsh S, Bloomfield MA, Veronese M, Kroll J, Karolis VR, Jauhar S, Bonoldi I, McGuire PK, Kapur S, Murray RM, Nosarti C, Howes O.

Elife. 2017 Nov 28;6. pii: e29088. doi: 10.7554/eLife.29088.

37.

Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities.

Rizzo G, Veronese M, Tonietto M, Bodini B, Stankoff B, Wimberley C, Lavisse S, Bottlaender M, Bloomfield PS, Howes O, Zanotti-Fregonara P, Turkheimer FE, Bertoldo A.

J Cereb Blood Flow Metab. 2019 May;39(5):874-885. doi: 10.1177/0271678X17742004. Epub 2017 Nov 14.

PMID:
29135382
38.

A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.

Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD.

JAMA Psychiatry. 2017 Dec 1;74(12):1206-1213. doi: 10.1001/jamapsychiatry.2017.2943.

39.

Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study.

Bonsall DR, Kokkinou M, Veronese M, Coello C, Wells LA, Howes OD.

J Neurochem. 2017 Dec;143(5):551-560. doi: 10.1111/jnc.14223. Epub 2017 Oct 26.

40.

Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.

Selvaraj S, Bloomfield PS, Cao B, Veronese M, Turkheimer F, Howes OD.

Schizophr Res. 2018 May;195:206-214. doi: 10.1016/j.schres.2017.08.063. Epub 2017 Oct 12.

41.

Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts.

Albrecht DS, Normandin MD, Shcherbinin S, Wooten DW, Schwarz AJ, Zürcher NR, Barth VN, Guehl NJ, Akeju O, Atassi N, Veronese M, Turkheimer F, Hooker JM, Loggia ML.

J Nucl Med. 2018 Jan;59(1):107-114. doi: 10.2967/jnumed.116.178335. Epub 2017 Aug 17.

42.

Kinetic modelling of [11C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis.

Veronese M, Reis Marques T, Bloomfield PS, Rizzo G, Singh N, Jones D, Agushi E, Mosses D, Bertoldo A, Howes O, Roncaroli F, Turkheimer FE.

J Cereb Blood Flow Metab. 2018 Jul;38(7):1227-1242. doi: 10.1177/0271678X17712388. Epub 2017 Jun 5.

43.

Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis.

Grecchi E, Veronese M, Bodini B, García-Lorenzo D, Battaglini M, Stankoff B, Turkheimer FE.

J Cereb Blood Flow Metab. 2017 Dec;37(12):3803-3817. doi: 10.1177/0271678X17712183. Epub 2017 Jun 1. Erratum in: J Cereb Blood Flow Metab. 2018 Jan 1;38(6):1120. J Cereb Blood Flow Metab. 2018 Jan 1;38(6):119.

44.

Protein synthesis is associated with high-speed dynamics and broad-band stability of functional hubs in the brain.

Hellyer PJ, Barry EF, Pellizzon A, Veronese M, Rizzo G, Tonietto M, Schütze M, Brammer M, Aurélio Romano-Silva M, Bertoldo A, Turkheimer FE.

Neuroimage. 2017 Jul 15;155:209-216. doi: 10.1016/j.neuroimage.2017.04.062. Epub 2017 May 2.

45.

Functional reorganization in obstructive sleep apnoea and insomnia: A systematic review of the resting-state fMRI.

Khazaie H, Veronese M, Noori K, Emamian F, Zarei M, Ashkan K, Leschziner GD, Eickhoff CR, Eickhoff SB, Morrell MJ, Osorio RS, Spiegelhalder K, Tahmasian M, Rosenzweig I.

Neurosci Biobehav Rev. 2017 Jun;77:219-231. doi: 10.1016/j.neubiorev.2017.03.013. Epub 2017 Mar 23. Review.

46.

Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits.

McGinnity CJ, Riaño Barros DA, Rosso L, Veronese M, Rizzo G, Bertoldo A, Hinz R, Turkheimer FE, Koepp MJ, Hammers A.

Neuroimage. 2017 May 15;152:270-282. doi: 10.1016/j.neuroimage.2016.12.038. Epub 2017 Mar 11.

47.

A Variational Bayesian inference method for parametric imaging of PET data.

Castellaro M, Rizzo G, Tonietto M, Veronese M, Turkheimer FE, Chappell MA, Bertoldo A.

Neuroimage. 2017 Apr 15;150:136-149. doi: 10.1016/j.neuroimage.2017.02.009. Epub 2017 Feb 14.

PMID:
28213113
48.

Erratum to: Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease.

Nair A, Veronese M, Xu X, Curtis C, Turkheimer F, Howard R, Reeves S.

EJNMMI Res. 2017 Dec;7(1):14. doi: 10.1186/s13550-017-0256-5. Epub 2017 Feb 14. No abstract available.

49.

Validation of an automatic reference region extraction for the quantification of [18F]DPA-714 in dynamic brain PET studies.

García-Lorenzo D, Lavisse S, Leroy C, Wimberley C, Bodini B, Remy P, Veronese M, Turkheimer F, Stankoff B, Bottlaender M.

J Cereb Blood Flow Metab. 2018 Feb;38(2):333-346. doi: 10.1177/0271678X17692599. Epub 2017 Feb 9.

50.

Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.

Jauhar S, Veronese M, Rogdaki M, Bloomfield M, Natesan S, Turkheimer F, Kapur S, Howes OD.

Transl Psychiatry. 2017 Feb 7;7(2):e1027. doi: 10.1038/tp.2016.270. Erratum in: Transl Psychiatry. 2018 Aug 31;8(1):171. Transl Psychiatry. 2019 Jun 11;9(1):168.

Supplemental Content

Loading ...
Support Center